Abstract: A nutritional composition for enteral feeding provides sole-source or supplemental nutrition via a nutrition shake for glycemic control that contains lower sugar and carbohydrates while being entirely plant-based and suitable for vegan, lactose-free, dairy-free, and gluten-free diets. The composition comprises pea protein, a balanced fat blend (e.g., sunflower, flaxseed, and medium chain triglycerides), an easy to digest carbohydrate blend (e.g., agave syrup, brown rice syrup solids, pea starch), with agave inulin fiber, and micronutrients. The nutritional composition has a low glycemic index while excluding artificial sweeteners, artificial flavors, corn syrup, sugar alcohols, lactose or milk protein, and common allergens. The composition includes a combination of ingredients specific to glycemic control, including plant-based omega-3 for cardiovascular health, phytonutrients such as quercetin and chlorogenic acid, and arginine to support nutritional needs of individuals with wounds.

Abstract: A nutritional composition for enteral and oral feeding provides sole-source or supplemental nutrition via a specialized formula for people on dialysis due to chronic kidney disease (CKD) or acute kidney injury (AKI), the formula being a calorically dense, high protein formula with optimized electrolyte content for people on dialysis due to CKD or AKI, while being entirely plant-based and suitable for vegan, lactose-free, dairy-free, and gluten-free diets. The nutritional composition comprises pea protein, a balanced fat blend (e.g., sunflower, flaxseed, and medium chain triglycerides), an easy to digest carbohydrate blend (e.g., agave syrup, brown rice syrup solids), with agave inulin fiber, and micronutrients. The nutritional composition provides relatively high amounts (e.g., compared to standard formulas) of certain micronutrients, including vitamin B6, vitamin B12, zinc, and/or selenium, and relatively low amounts of sodium, potassium, and phosphorus to meet the needs of CKD patients on dialysis.

Abstract: Disclosed herein are methods and compositions for the modulation of the activity of electrically excitable cells. In particular, several embodiments relate to the use of photovoltaic compounds which, upon exposure to light energy, increase or decrease the electrical activity of cells.

Abstract: Methods and compositions modulate the activity of electrically excitable cells. Photovoltaic compounds which, upon exposure to light energy, increase or decrease the electrical activity of cells. These supplement and/or replace of vision based on the conversion of light energy to electrical energy within certain cells of the visual system. A “patch” or bridge to circumvent one or more defective, damaged, or diseased cells in the visual system. Additionally, in several embodiments, subjects with normal vision can benefit from the methods, compositions, systems, and/or devices disclosed herein as normal visual acuity can be heightened. The exposure induces an energy (e.g., a receipt of light energy, conversion to electrical energy, and passage of that electrical energy) from the photovoltaic compound to the cell, thereby altering the transmembrane potential of the cell and/or the opening of one or more ion channels, thereby modulating the activity of the electrically excitable cell.